Product Information
GLYBURIDE 1.25 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0674 per EA under NDC 00093834201. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 29, 1995. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093834201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GLYBURIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074388FDA Approved
8/29/1995
TE Code
AB1
On Market Since
8/30/1995
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 1.25 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0674 per EA |
|---|---|
| All-time high | $0.1443 (Dec 11, 2019) |
| All-time low | $0.0561 (Jun 19, 2024) |
| 52-week high | $0.0873 |
| 52-week low | $0.0666 |
| Median price | $0.0942 |
| Average price | $0.0955 |
| Largest weekly change | +71.9% (Sep 18, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYBURIDE 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 1.25 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0674 per EA (NDC 00093834201), effective Aug 19, 2026.
How has the price of GLYBURIDE 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 1.25 MG TABLET has declined 44.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 1.25 MG TABLET?
Since Nov 28, 2013, the NADAC for GLYBURIDE 1.25 MG TABLET has ranged from a low of $0.0561 (Jun 19, 2024) to a high of $0.1443 (Dec 11, 2019), with a median of $0.0942 per EA.
Are there cheaper alternatives to GLYBURIDE 1.25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GLYBURIDE 1.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYBURIDE 1.25 MG TABLET?
GLYBURIDE 1.25 MG TABLET (NDC 00093834201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.